<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38146337</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Treatment of Cognitive Deficits and Behavioral Symptoms Following COVID-19-Associated Autoimmune Encephalitis With Intravenous Immunoglobulin: A Case Report and Review of the Literature.</ArticleTitle><Pagination><StartPage>e51071</StartPage><MedlinePgn>e51071</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e51071</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.51071</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 (COVID-19) is associated with long-term neuropsychiatric sequelae. We describe a 60-year-old male patient's&#xa0;history and&#xa0;symptom&#xa0;trajectory&#xa0;encompassing the development of behavioral symptoms and cognitive deficits following&#xa0;pneumonia and subsequent autoimmune encephalitis&#xa0;associated with COVID-19. We also describe changes in these facets with correlative changes in his immunological parameters after both acute intravenous immunoglobulin (IVIG) therapy and chronic periodic IVIG therapy every two weeks over the course of two years. &#x200b;&#x200b;&#x200b;&#x200b;&#x200b;&#x200b;We review the literature on the treatment of long COVID-19 symptoms spanning cognitive and behavioral domains. In addition, we also&#xa0;elucidate current literature on the role of&#xa0;IVIG infusions for these symptoms using our patient's presentation and improvement in symptoms as an illustrative example.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Naeem et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Naeem</LastName><ForeName>Suniya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Child Psychiatry, Washington University School of Medicine, St. Louis Children's Hospital, St Louis, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oros</LastName><ForeName>Sarah M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Psychiatry/Internal Medicine, University of Kentucky College of Medicine, Lexington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adams</LastName><ForeName>Christian S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Psychiatry, University of Kentucky College of Medicine, Lexington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rakesh</LastName><ForeName>Gopalkumar</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Psychiatry, University of Kentucky College of Medicine, Lexington, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">behavioral disorder</Keyword><Keyword MajorTopicYN="N">cognitive deficits</Keyword><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">encephalitis</Keyword><Keyword MajorTopicYN="N">intravenous immunoglobulin therapy</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>26</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>26</Day><Hour>3</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38146337</ArticleId><ArticleId IdType="pmc">PMC10749582</ArticleId><ArticleId IdType="doi">10.7759/cureus.51071</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study. Reyes LF, Murthy S, Garcia-Gallo E, et al. ERJ Open Res. 2022;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8669808</ArticleId><ArticleId IdType="pubmed">35169585</ArticleId></ArticleIdList></Reference><Reference><Citation>Encephalitis as a neurological complication of COVID-19: a systematic review and meta-analysis of incidence, outcomes, and predictors. Siow I, Lee KS, Zhang JJ, Saffari SE, Ng A. Eur J Neurol. 2021;28:3491&#x2013;3502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239820</ArticleId><ArticleId IdType="pubmed">33982853</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID: major findings, mechanisms and recommendations. Davis HE, McCorkell L, Vogel JM, Topol EJ. Nat Rev Microbiol. 2023;21:133&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-COVID cognitive dysfunction: current status and research recommendations for high risk population. Quan M, Wang X, Gong M, Wang Q, Li Y, Jia J. Lancet Reg Health West Pac. 2023;38:100836.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10344681</ArticleId><ArticleId IdType="pubmed">37457901</ArticleId></ArticleIdList></Reference><Reference><Citation>Efficacy of intravenous immunoglobulin (IVIg) on COVID-19-related neurological disorders over the last 2 years: an up-to-date narrative review. Manganotti P, Garascia G, Furlanis G, Buoite Stella A. Front Neurosci. 2023;17:1159929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10166837</ArticleId><ArticleId IdType="pubmed">37179564</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmune encephalitis following recovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection . Yousuf F, King R, Ainger T, Hessler A. https://n.neurology.org/content/96/15_Supplement/2756.abstract American Academy of Neurology Conference Presentation Poster # 2756. 2021</Citation></Reference><Reference><Citation>Long-term high-dose immunoglobulin successfully treats Long COVID patients with pulmonary, neurologic, and cardiologic symptoms. Thompson JS, Thornton AC, Ainger T, Garvy BA. Front Immunol. 2022;13:1033651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9932260</ArticleId><ArticleId IdType="pubmed">36818469</ArticleId></ArticleIdList></Reference><Reference><Citation>Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis. Probasco JC, Solnes L, Nalluri A, et al. Neurol Neuroimmunol Neuroinflamm. 2017;4:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5442608</ArticleId><ArticleId IdType="pubmed">28567435</ArticleId></ArticleIdList></Reference><Reference><Citation>A clinical approach to diagnosis of autoimmune encephalitis. Graus F, Titulaer MJ, Balu R, et al. Lancet Neurol. 2016;15:391&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5066574</ArticleId><ArticleId IdType="pubmed">26906964</ArticleId></ArticleIdList></Reference><Reference><Citation>Dexamethasone in hospitalized patients with Covid-19. Horby P, Lim WS, Emberson JR, et al. N Engl J Med. 2021;384:693&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Early steroids and ventilator-associated pneumonia in COVID-19-related ARDS. Lamouche-Wilquin P, Souchard J, Pere M, et al. Crit Care. 2022;26:233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9344449</ArticleId><ArticleId IdType="pubmed">35918776</ArticleId></ArticleIdList></Reference><Reference><Citation>Corticosteroids, COVID-19 pneumonia, and acute respiratory distress syndrome. Matthay MA, Wick KD. J Clin Invest. 2020;130:6218&#x2013;6221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7685752</ArticleId><ArticleId IdType="pubmed">32976118</ArticleId></ArticleIdList></Reference><Reference><Citation>Steroid exposure and outcome in COVID-19 pneumonia. Remmington C, Barrett NA, Agarwal S, et al. BJA Open. 2023;5:100128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9886648</ArticleId><ArticleId IdType="pubmed">36744291</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychiatric disorders following SARS-CoV-2 infection. Harrison PJ, Taquet M. Brain. 2023;146:2241&#x2013;2247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10232232</ArticleId><ArticleId IdType="pubmed">36729559</ArticleId></ArticleIdList></Reference><Reference><Citation>Retraction. Biol Psychiatry. 2022;92:523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9393473</ArticleId><ArticleId IdType="pubmed">36008037</ArticleId></ArticleIdList></Reference><Reference><Citation>Update on intravenous immunoglobulin in neurology: modulating neuro-autoimmunity, evolving factors on efficacy and dosing and challenges on stopping chronic IVIG therapy. Dalakas MC. Neurotherapeutics. 2021;18:2397&#x2013;2418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8585501</ArticleId><ArticleId IdType="pubmed">34766257</ArticleId></ArticleIdList></Reference><Reference><Citation>A proposed dosing algorithm for the individualized dosing of human immunoglobulin in chronic inflammatory neuropathies. Lunn MP, Ellis L, Hadden RD, Rajabally YA, Winer JB, Reilly MM. J Peripher Nerv Syst. 2016;21:33&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">26757367</ArticleId></ArticleIdList></Reference><Reference><Citation>From 'mental fog' to post-acute COVID-19 syndrome's executive function alteration: implications for clinical approach. Pallanti S, Di Ponzio M, Gavazzi G, et al. J Psychiatr Res. 2023;167:10&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">37804756</ArticleId></ArticleIdList></Reference><Reference><Citation>Changes in cognitive functioning after COVID-19: a systematic review and meta-analysis. Crivelli L, Palmer K, Calandri I, et al. Alzheimers Dement. 2022;18:1047&#x2013;1066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9073922</ArticleId><ArticleId IdType="pubmed">35297561</ArticleId></ArticleIdList></Reference><Reference><Citation>Evidences that SARS-CoV-2 Vaccine-Induced apoplexy may not be solely due to ASIA or VITT syndrome', Commentary on Pituitary apoplexy and COVID-19 vaccination: a case report and literature review. Taieb A, Asma BA, Mounira EE. Front Endocrinol (Lausanne) 2023;14:1111581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9907727</ArticleId><ArticleId IdType="pubmed">36761192</ArticleId></ArticleIdList></Reference><Reference><Citation>A possible case of autoimmune encephalitis after mRNA COVID-19 booster vaccine: a case report. Abu-Abaa M, Dawood G, Arshad H, Jumaah O, Landau D. Cureus. 2022;14:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9720496</ArticleId><ArticleId IdType="pubmed">36479395</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilot findings on SARS-CoV-2 vaccine-induced pituitary diseases: a mini review from diagnosis to pathophysiology. Taieb A, Mounira EE. Vaccines (Basel) 2022;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9786744</ArticleId><ArticleId IdType="pubmed">36560413</ArticleId></ArticleIdList></Reference><Reference><Citation>Cognitive inhibition deficit in long COVID-19: an exploratory study. Saucier J, Jose C, Beroual Z, et al. Front Neurol. 2023;14:1125574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10140516</ArticleId><ArticleId IdType="pubmed">37122293</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>